Patent details
EP3684334 Title: PHARMACEUTICAL COMPOSITIONS OF ROFLUMILAST IN AQUEOUS BLENDS OF WATER-MISCIBLE, PHARMACEUTICALLY ACCEPTABLE SOLVENTS
Basic Information
- Publication number:
- EP3684334
- PCT Application Number:
- US2018051691
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP187832506
- PCT Publication Number:
- WO2019060379
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- PHARMACEUTICAL COMPOSITIONS OF ROFLUMILAST IN AQUEOUS BLENDS OF WATER-MISCIBLE, PHARMACEUTICALLY ACCEPTABLE SOLVENTS
- French Title of Invention:
- COMPOSITIONS PHARMACEUTIQUES DE ROFLUMILAST DANS DES MÉLANGES AQUEUX DE SOLVANTS PHARMACEUTIQUEMENT ACCEPTABLES MISCIBLES À L'EAU
- German Title of Invention:
- PHARMAZEUTISCHE ZUSAMMENSETZUNGEN VON ROFLUMILAST IN WÄSSRIGEN MISCHUNGEN VON MIT WASSER MISCHBAREN, PHARMAZEUTISCH VERTRÄGLICHEN LÖSUNGSMITTELN
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 02/01/2024
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 11/01/2024
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 06/12/2023
- Unitary Effect Registration Date:
- 11/01/2024
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 19/09/2018
- Grant date:
- 06/12/2023
- EP Publication Date:
- 29/07/2020
- PCT Publication Date:
- 28/03/2019
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 06/12/2023
- EP B1 Publication Date:
- 06/12/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 19/09/2038
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 29/11/2023
- Name:
- Arcutis Biotherapeutics, Inc.
- Address:
- 3027 Townsgate Road, Suite 300, Westlake Village, CA 91361, United States (US)
Inventor
- Name:
- OSBORNE, David W.
- Address:
- United States (US)
Priority
- Priority Number:
- 201715712900
- Priority Date:
- 22/09/2017
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 9/00; A61K 47/10; A61K 9/06; A61K 31/44; A61P 17/00;
Publication
European Patent Bulletin
1
- Issue number:
- 202349
- Publication date:
- 06/12/2023
- Description:
- Grant (B1)
2
- Issue number:
- 202402
- Publication date:
- 10/01/2024
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
3
- Issue number:
- 202406
- Publication date:
- 07/02/2024
- Description:
- Unitary Effect Request Receipt
4
- Issue number:
- 202407
- Publication date:
- 14/02/2024
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|